Remove Hypertension Remove Innovation Remove Patient Care
article thumbnail

Clinical Study Highlights Research on AI that Takes on Cardiopulmonary Killer

DAIC

6, 2025 Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announcedpublication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH). tim.hodson Mon, 02/10/2025 - 12:43 Feb.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

For 19 years, the Cardiometabolic Health Congress (CMHC) has worked towards a vision of a better future for clinicians, patients, and the entire health sector. This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L.

Education 100
article thumbnail

How to Choose the Right Patient Engagement Platform for Your Cardiology Practice in 2025

GEMMS

For cardiology practices, choosing the right patient engagement platform is vital for improving outcomes, optimizing workflow, and maintaining a competitive edge. Cardiology practices must choose a platform that fosters meaningful patient-provider interactions. This will make both administrative tasks and patient care more efficient.

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64
article thumbnail

World Stroke Day: Understanding and Combating the "Silent Killer"

ADN Center of Excellence

Some of the latest strategies include: Innovations in Thrombolysis and Clot Retrieval : Techniques such as tissue plasminogen activator (tPA) injections and mechanical thrombectomy are significantly improving recovery rates for ischemic stroke patients. www.adncoe.com

Stroke 59
article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Join us at the 19th Annual CMHC , where we’ll delve deeper into these innovations and their implications for clinical practice.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. One promising strategy is the formation of creative partnerships between patients and their healthcare teams. Key contributions: Advanced cardiac imaging (e.g.,